Evidence map›Paper›PMID 34996424›Full record

Trial reportBMC women's health2022

Internet-based cognitive-behavioral therapy for premenstrual syndrome: a randomized controlled trial.

Sanam Borji-Navan, Sakineh Mohammad-Alizadeh-Charandabi, Khalil Esmaeilpour, Mojgan Mirghafourvand, Ali Ahmadian-Khooinarood

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06431646 (Evaluation of the Effectiveness of Web-Based Education on Premenstrual Syndrome), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06431646 nacompletednot on this map

Evaluation of the Effectiveness of Web-Based Education on Premenstrual Syndrome (PMS) Symptoms and Quality of Life

TypeinterventionalSponsorPamukkale UniversityRan2022 to 2022Enrolled67ConditionsPremenstrual Syndrome, Quality of LifeArmsA web-based education intervention developed for university students with PMS
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Management of Premenstrual Dysphoric Disorder: A Scoping Review.International journal of women's health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sanam Borji-NavanStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0002-1198-8881
Sakineh Mohammad-Alizadeh-CharandabiSocial Determinants of Health Research Centre, Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, South Shariati Street, Tabriz, 5137975846, Iran. mhammadalizadehs@gmail.com.ORCID 0000-0003-4785-9333
Khalil EsmaeilpourDepartment of Psychology, Faculty of Education and Psychology, University of Tabriz, Tabriz, Iran.ORCID 0000-0001-6948-2077
Mojgan MirghafourvandClinical Research Development Unit, Imam Reza General Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0001-8360-4309
Ali Ahmadian-KhooinaroodEducation Development Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-1253-9241
Tabriz University of Medical Sciences · IRUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPremenstrual syndrome (PMS) is a common problem of women of reproductive age, affecting various aspects of their lives. However, limited studies have investigated the effect of internet-based cognitive-behavioral therapy (ICBT) on PMS. Therefore, we aimed to assess whether ICBT can reduce symptom severity of women with PMS and improve their quality of life during the perimenstrual and late follicular phases of menstrual cycle.

methodsThe study included 92 university students aged 18-35 years who had moderate to severe PMS. The participants were allocated into two groups of 46 using block randomization. The intervention group underwent ICBT for two menstrual cycles, while the control group received no intervention. Before and after the intervention, all participants filled the Daily Record of Severity of Problems (DRSP) for two menstrual cycles and the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF) on days 1-2 and 11-13 of the menstrual cycle. Data were analyzed using univariate general linear models.

resultsFour students in the intervention group were lost to follow-up. Following the intervention, the mean score of total PMS symptoms was significantly lower in the intervention group than in the control group (10.4 vs. 20.2, adjusted difference: - 9.9 [95% CI - 13.3 to - 6.6]), and the score of perimenstrual quality of life was significantly higher (64.2 vs. 50.3, 14.1 [8.5 to 19.8]). However, there was no significant intergroup difference in the late follicular quality of life (68.3 vs. 67.3, 1.9 [- 4.4 to 8.1]).

conclusionsThe ICBT could reduce the symptom severity of women suffering from PMS while improving their perimenstrual quality of life. However, it had no significant effect on the late follicular quality of life. Therefore, this intervention can be used for women with PMS. Trial registration The Iranian Registry of Clinical Trials, Identifier: IRCT20100414003706N34, Registered prospectively on 19 June 2019, https://www.irct.ir/trial/38394 .

Indexed as

Cognitive Behavioral TherapyPremenstrual SyndromeFemaleHumansInternetIranQuality of LifeCognitive behavior therapyICBTInternet-based treatmentPremenstrual syndromeQuality of life

Identifiers

PMID34996424
PMCPMC8741531
OpenAlexW4226088484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.